MDM2 and cancer: Restoration of PTEN, the development of small molecule inhibitors of PI3K and its targets, including MDM2, or elevation of p53 expression in tumor cells through gene therapy could inhibit tumor growth and sensitize refractory cancers to chemotherapy.